keyword
https://read.qxmd.com/read/38602399/comparison-of-targeted-next-generation-sequencing-and-the-xpert-mtb-rif-assay-for-detection-of-mycobacterium-tuberculosis-in-clinical-isolates-and-sputum-specimens
#1
JOURNAL ARTICLE
Hongtai Zhang, Xiaowei Dai, Peilei Hu, Lili Tian, Chuanyou Li, Beichuan Ding, Xinyu Yang, Xiaoxin He
Targeted next-generation sequencing (tNGS) can be used to perform Mycobacterium tuberculosis (MTB) complex-specific amplification or target capture directly from sputum samples, yielding simultaneous coverage of many genes and DNA regions associated with antimicrobial resistance (AMR). Performance comparisons of tNGS and another molecular testing tool, Xpert MTB/rifampicin (RIF), have been empirical. Here, using a dilution series of a RIF-resistant clinical isolate of MTB, we found that tNGS had a slightly lower limit of bacterial detection (102 CFU/mL) compared with Xpert MTB/RIF (103 CFU/mL) in culture medium...
April 11, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38599814/-annual-progress-of-interventional-diagnosis-and-treatment-of-tuberculosis-in-2023
#2
REVIEW
S Yang, J Q Guo, T X Li, S J Tang
A series of studies on the interventional diagnosis and treatment of tuberculosis(TB)were carried out by domestic and foreign researchers in 2023. The combination of minimally invasive interventional procedures with endoscopes, guidance, material acquisition techniques by multiple ways and multichannel and highly accurate laboratory testing techniques is becoming more and more widely practiced clinically, which has played an important role in the accurate diagnosis of problematic TB. Diagnostic procedures for pulmonary TB, tracheobronchial TB, mediastinal lymphatic TB and extrapulmonary TB included conventional flexible bronchoscopy and specific types of bronchoscopy(ultrathin bronchoscopy and endobronchial ultrasound), transbronchial needle aspiration biopsy, endobronchial ultrasound and virtual bronchoscopic navigation system-guided forceps biopsy, thoracoscopic cryobiopsy of pleura, percutaneous biopsy, and so on...
April 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38563336/smart-pcr-sampling-using-masks-and-rt-pcr-a-non-invasive-diagnostic-tool-for-paediatric-pulmonary-tb
#3
JOURNAL ARTICLE
A Shaikh, K Sriraman, S Vaswani, I Shah, V Poojari, V Oswal, S Mane, S Rajagara, N Mistry
<sec id="st1"><title>BACKGROUND</title>Key challenges in paediatric TB diagnosis are invasive sampling and poor sensitivity of standard methods. This study demonstrates the diagnostic potential of non-invasive sampling of bioaerosols from children using SMaRT-PCR, comprising mask sampling combined with reverse transcriptase-polymerase chain reaction (RT-PCR) for TB.</sec><sec id="st2"><title>METHODS</title>Exhaled bioaerosols were captured on modified N-95 masks in a 10-min talk-cough-breathe process from 51 children (30 with TB confirmed using standard sampling methods and 21 without TB) aged 2-15 years...
April 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38495513/rapid-detection-of-multidrug-resistance-in-tuberculosis-using-nanopore-based-targeted-next-generation-sequencing-a-multicenter-double-blind-study
#4
JOURNAL ARTICLE
Aimei Liu, Sang Liu, Kangyan Lv, Qingdong Zhu, Jun Wen, Jianpeng Li, Chengyuan Liang, Xuegang Huang, Chunming Gong, Qingfeng Sun, Hongcang Gu
BACKGROUND: Resistance to anti-tuberculous drugs is a major challenge in the treatment of tuberculosis (TB). We aimed to evaluate the clinical availability of nanopore-based targeted next-generation sequencing (NanoTNGS) for the diagnosis of drug-resistant tuberculosis (DR-TB). METHODS: This study enrolled 253 patients with suspected DR-TB from six hospitals. The diagnostic efficacy of NanoTNGS for detecting Mycobacterium tuberculosis and its susceptibility or resistance to first- and second-line anti-tuberculosis drugs was assessed by comparing conventional phenotypic drug susceptibility testing (pDST) and Xpert MTB/RIF assays...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38489738/impact-of-delayed-diagnosis-and-treatment-on-tuberculosis-infection-within-families-a-case-report
#5
JOURNAL ARTICLE
Jian-Jun Liu, Yin-Ping Feng, Zhong-Da Liu, Jing Guo
BACKGROUND: A 32-year-old male patient was diagnosed with a 30% left pneumothorax on November 5, 2020, during which chest imaging indicated abnormalities. Despite this, pulmonary tuberculosis (TB) was not diagnosed or treated at that time due to a negative result in the MGIT960 culture. The patient experienced symptoms of cough and expectoration on April 24, 2022. Upon repeating the chest imaging, the condition had worsened, confirming the presence of pulmonary TB, leading to the patient's hospitalization...
March 15, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38469390/-mycobacterium-tuberculosis-lineage-distribution-using-whole-genome-sequencing-and-bedaquiline-clofazimine-and-linezolid-phenotypic-profiles-among-rifampicin-resistant-isolates-from-west-java-indonesia
#6
JOURNAL ARTICLE
Andriansjah Rukmana, Cynthia Gozali, Linda Erlina
Tuberculosis (TB) is caused by Mycobacterium tuberculosis infection. Indonesia is ranked second in the world for TB cases. New anti-TB drugs from groups A and B, such as bedaquiline, clofazimine, and linezolid, have been shown to be effective in curing drug resistance in TB patients, and Indonesia is already using these drugs to treat patients. However, studies comparing the TB strain types with anti-TB resistance profiles are still relevant to understanding the prevalent strains in the country and their phenotypic characteristics...
2024: International Journal of Microbiology
https://read.qxmd.com/read/38383366/prevalence-of-genital-high-risk-human-papillomavirus-infections-and-associated-factors-among-women-living-with-human-immunodeficiency-virus-in-uganda
#7
JOURNAL ARTICLE
Harriet Nakigozi, Rawlance Ndejjo, William Bazeyo, Annet Nabaggala, Caroline Achola, Moses Iga, Simeon Kalyesubula, Ben Kanamwangi, Gerald Mutungi, Charles Batte, David Mukunya, Lawrence Sserwanga, Godfrey Gemageine, Charles Akiya Oyoo, Susan Nabadda
BACKGROUND: Women living with HIV are at risk for cervical dysplasia and cancer worldwide. In 2015, the World Health Organization (WHO) recommended that testing for high-risk HPV (hrHPV) infection be incorporated into cervical cancer screening programs using molecular nucleic acid tests (NATs) but this has not previously been done in Uganda. The country's coverage for Human Papilloma Virus (HPV) screening remains low at less than 10% for women aged 25-49 years. This study determined the genital prevalence of hrHPV infection and the associated factors among women living with HIV in Uganda...
February 21, 2024: BMC Cancer
https://read.qxmd.com/read/38350885/performance-evaluation-of-truenat-mtb-and-truenat-mtb-rif-dx-assays-in-comparison-to-gene-xpert-mtb-rif-ultra-for-the-diagnosis-of-pulmonary-tuberculosis-in-uganda
#8
JOURNAL ARTICLE
Willy Ssengooba, Achilles Katamba, James Sserubiri, Derrick Semugenze, Abdunoor Nyombi, Raymond Byaruhanga, Stavia Turyahabwe, Moses L Joloba
BACKGROUND: The World Health Organization endorsed Truenat MTB rapid molecular assay in 2020 and recommended additional in-country evaluation studies before uptake. We evaluated the accuracy and operational feasibility of Truenat MTB assay (Truenat) in comparison with GeneXpert Ultra and culture. METHODS: In a cross-sectional study of 250 presumptive TB patients, participants were requested to provide a sputum sample on the day of their visit to the clinic. The sputum sample was homogenized and a portion was tested using GeneXpert Ultra as per the routine standard procedure and the other portion was tested using Truenat assay at the clinic laboratory...
February 13, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38321542/prognostic-impact-of-her2-biomarker-levels-in-trastuzumab-treated-early-her2-positive-breast-cancer
#9
JOURNAL ARTICLE
Caroline Rönnlund, Emmanouil G Sifakis, Caroline Schagerholm, Qiao Yang, Emelie Karlsson, Xinsong Chen, Theodoros Foukakis, Jodi Weidler, Michael Bates, Irma Fredriksson, Stephanie Robertson, Johan Hartman
BACKGROUND: Overexpression of human epidermal growth factor receptor 2 (HER2) caused by HER2 gene amplification is a driver in breast cancer tumorigenesis. We aimed to investigate the prognostic significance of manual scoring and digital image analysis (DIA) algorithm assessment of HER2 copy numbers and HER2/CEP17 ratios, along with ERBB2 mRNA levels among early-stage HER2-positive breast cancer patients treated with trastuzumab. METHODS: This retrospective study comprised 371 early HER2-positive breast cancer patients treated with adjuvant trastuzumab, with HER2 re-testing performed on whole tumor sections...
February 7, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38290212/primary-pituitary-tuberculoma-with-a-pituitary-apoplexy-like-presentation
#10
JOURNAL ARTICLE
Gaayathri Krishnan, Nur Hidayah Mohd Makhatar, Tee Hwee Ching, Serena Khoo
SUMMARY: Pituitary tuberculoma is extremely rare and may pose as a diagnostic challenge especially when encountered as an isolated lesion without other systemic manifestation of tuberculosis. A 21-year-old female was admitted for diabetic ketoacidosis. On the third day of admission following the resolution of diabetic ketoacidosis she developed a sudden onset of headache and blurring of vision suggestive of pituitary apoplexy. An urgent MRI brain revealed a large sellar mass with erosion into the sphenoid sinus and intracranial vasculitis...
January 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38270458/the-elusive-allure-of-a-rapid-host-blood-signature-for-tuberculosis-disease
#11
JOURNAL ARTICLE
Paul K Drain, Ronit R Dalmat
A rapid host transcriptional signature cartridge could be a major advancement for tuberculosis diagnosis and treatment monitoring. In a recent study, M. Li, Y. Qiu, M. Guo, R. Qu, et al. (J Clin Microbiol 61:e00911-23, 2023, https://doi.org/10.1128/jcm.00911-23) conducted an evaluation of the Cepheid 3-gene assay (Xpert-MTB-HR) within a diagnostic case-control study in China. While the study provides a strong contribution for determining the value of the Xpert-MTB-HR assay for diagnostic accuracy and treatment response, further assay optimization and more prospective studies are necessary before adaptation into clinical practice...
January 25, 2024: Journal of Clinical Microbiology
https://read.qxmd.com/read/38161967/clinical-microbiological-and-genomic-characterization-of-gram-negative-bacteria-with-dual-carbapenemases-as-identified-by-rapid-molecular-testing
#12
JOURNAL ARTICLE
Ammara Mushtaq, Bremy Alburquerque, Marilyn Chung, Shelcie Fabre, Mitchell J Sullivan, Michael Nowak, Emilia M Sordillo, Jose Polanco, Harm van Bakel, Melissa R Gitman
OBJECTIVE: Dual carbapenemase-producing organisms (DCPOs) are an emerging threat that expands the spectrum of antimicrobial resistance. There is limited literature on the clinical and genetic epidemiology of DCPOs. METHODS: DCPO isolates were identified by Xpert® Carba-R PCR testing of routine diagnostic cultures performed from 2018 to 2021 at a New York City health system. WGS was performed by Illumina and/or PacBio. Medical records of patients were reviewed for clinical and epidemiological data...
February 2024: JAC-antimicrobial resistance
https://read.qxmd.com/read/38159724/first-detection-in-spain-of-ndm-1-producing-pseudomonas-aeruginosa-in-two-patients-transferred-from-ukraine-to-a-university-hospital
#13
JOURNAL ARTICLE
Marta Hernández-García, Margarita Cabello, Manuel Ponce-Alonso, Pedro M Herrador-Gómez, Francesca Gioia, Javier Cobo, Rafael Cantón, Patricia Ruiz-Garbajosa
OBJECTIVES: Carbapenemase-mediated carbapenem resistance in Pseudomonas aeruginosa is a relevant health problem. We detected for the first time in Spain two clinical NDM-producing P. aeruginosa (NDM-Pa) isolates in two Ukrainian patients admitted to our hospital between April-August 2022. METHODS: Antimicrobial susceptibility was studied by microdilution and MIC gradient strips (EUCAST-2022 criteria). Carbapenemase genes were detected by the Xpert Carba-R and immunochromatography assays...
December 28, 2023: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/38152299/pulmonary-tuberculosis-and-multidrug-resistant-mycobacterium-tuberculosis-in-northwestern-ethiopia-a-hospital-based-cross-sectional-study-among-presumptive-pulmonary-tuberculosis-patients
#14
JOURNAL ARTICLE
Birhanu Wubu, Mohabaw Jemal, Yihenew Million, Mucheye Gizachew
INTRODUCTION: Border areas are important sites for disseminating Mycobacterium tuberculosis among individuals living in such areas. This study examined patients with suspected pulmonary tuberculosis (PTB) visiting the Abrihajira and Metema hospitals in northwest Ethiopia to investigate the prevalence of rifampicin-resistant Mycobacterium tuberculosis (RR-MTB), multidrug-resistant Mycobacterium tuberculosis (MDR-MTB), and risk factors related to Mycobacterium tuberculosis infection. METHODS: A hospital-based cross-sectional study was conducted from February to August 2021 among 314 PTB presumptive patients...
2023: Frontiers in Medicine
https://read.qxmd.com/read/38145052/diagnostic-value-of-chemiluminescence-for-urinary-lipoarabinomannan-antigen-assay-in-active-tuberculosis-insights-from-a-retrospective-study
#15
JOURNAL ARTICLE
Luyi Huang, Yayan Niu, Li Zhang, Rong Yang, Meiying Wu
PURPOSE: This study aimed to assess the efficacy of chemiluminescence-based urinary lipoarabinomannan (LAM) antigen assay as a diagnostic tool for identifying active tuberculosis. METHODS: A retrospective study was conducted on 166 Tuberculosis (TB), 22 Non-Tuberculous Mycobacteria (NTM), 69 Non-TB cases, and 73 healthy controls from Zhangjiagang First Peoples Hospital between July 2022 and November 2022. Clinical and laboratory data were collected, including urine samples for LAM antigen detection, sputum samples and pleural effusion for GeneXpert, TB-DNA, and culture...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38110261/missed-phenotypic-drug-resistance-in-pediatric-tuberculosis-a-cause-of-concern-in-a-resource-limited-setting
#16
JOURNAL ARTICLE
Bineeta Kashyap, Sapna Jhanjharia, Rituparna Saha, Sunil Gomber
BACKGROUND: Multi-drug resistance (MDR) in pediatric tuberculosis (TB) is a growing global threat. Unavailability of conventional or molecular drug susceptibility test (DST) in resource-limited settings often impede the determination of the extent of first line anti-tubercular drugs deployed in national programs. MATERIALS AND METHOD: Pulmonary and extra pulmonary specimens were collected from clinically suspected pediatric TB cases, who were microbiologically confirmed...
2023: Indian Journal of Tuberculosis
https://read.qxmd.com/read/38041961/in-vivo-expressed-mycobacterial-transcripts-as-diagnostic-targets-for-pulmonary-tuberculosis
#17
JOURNAL ARTICLE
Sumedha Sharma, Ashutosh N Aggarwal, Prabhdeep Kaur, Rakesh Yadav, Sunil Sethi, Indu Verma
The nucleic acid amplification tests (NAATs) such as Xpert MTB/RIF have transformed the TB diagnostic field by significantly increasing the case detection. However, newer improved diagnostic assays are still needed to meet the WHO targets to end TB. Present study is based on a novel approach of utilizing the in-vivo expressed specific mycobacterial transcriptomic biomarkers for the diagnosis of pulmonary tuberculosis (PTB). Total 61 subjects were recruited including smear positive (smear+; n = 15), smear negative (smear-; n = 30) PTB patients and disease controls (n = 16)...
November 27, 2023: Tuberculosis
https://read.qxmd.com/read/38029234/a-preliminary-evaluation-of-targeted-nanopore-sequencing-technology-for-the-detection-of-mycobacterium-tuberculosis-in-bronchoalveolar-lavage-fluid-specimens
#18
JOURNAL ARTICLE
Xiaoke Sun, Jingchao Song, Xia Leng, Fuli Li, Haojie Wang, Jiaqian He, Wenhua Zhai, Zhenjing Wang, Qingqing Wu, Zheng Li, Xianglin Ruan
OBJECTIVE: To evaluate the efficacy of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis ( M.tb. ) in bronchoalveolar lavage fluid(BALF) specimens. METHODS: A prospective study was used to select 58 patients with suspected pulmonary tuberculosis(PTB) at Henan Chest Hospital from January to October 2022 for bronchoscopy, and BALF specimens were subjected to acid-fast bacilli(AFB) smear, Mycobacterium tuberculosis MGIT960 liquid culture, Gene Xpert MTB/RIF (Xpert MTB/RIF) and targeted nanopore sequencing (TNS) for the detection of M...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/37970780/case-fatality-rate-of-childhood-tuberculosis-experience-from-federal-teaching-hospital-gombe-a-two-decade-review
#19
W E Isaac, I Jalo, G Yohanna, A Rasaki, K Ebisike, A Girbo, L Olatoke, P M Raymond, A Iliya, V Ndubusi, Y Rabo, G E Daniel, D Apollos, B Bakura, O Maryam, A Bello, Z Joel, H Tukur, H Abdulkarim, O A Adeniran, S Abdulrahman, T Meller, A Adamu, B A Ibrahim
INTRODUCTION: Tuberculosis (TB) was the leading cause of death from an infectious agent worldwide, until the Coronavirus (COVID-19) pandemic, ranking above HIV/AIDS. Nigeria ranks 6th among the 30 TB high-burden countries (TB, TB/HIV, DRTB) and 1st in Africa. The estimated case fatality rate (CFR) of TB in Sub-Sahara Africa (SSA) is 15%. OBJECTIVE: To review the Tuberculosis case fatality rate (TCFR) in children diagnosed with TB from 2000-2019 in Federal Teaching Hospital Gombe...
November 10, 2023: West African Journal of Medicine
https://read.qxmd.com/read/37948480/amplification-failure-by-the-cepheid-xpert-xpress-sars-cov-2-assay-due-to-a-single-nucleotide-variant-of-the-n-gene-in-the-omicron-variant
#20
JOURNAL ARTICLE
Sunghwan Shin, Tae Hyun Um, Chong Rae Cho, Jeonghyun Chang
BACKGROUND: Rapid identification of SARS-CoV-2 infection using molecular testing has played an important role in preventing the spread of COVID-19. However, the failure of SARS-CoV-2 N gene amplification in the Cepheid Xpert SARS-CoV-2 assay could lead to the failed detection of infections, possibly leading to spread. In this study, we examined N gene amplification failure due to a single-nucleotide variant (SNV) in the N2 region of the gene. METHODS: Xpert assay results obtained at our hospital since March 2021 were retrospectively reviewed and samples with strong E gene and failed N gene amplification were selected...
November 1, 2023: Clinical Laboratory
keyword
keyword
63644
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.